Navigation Links
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Date:8/28/2007

s, stock offerings and future revenues; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers. These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2008)...This analysis showed that Multaq(R) (dronedarone) ...h atrial fibrillation or atrial flutter already ...erapy, BRIDGEWATER, N.J., Sept. 3 /PRNewswire-Fir...he data from the ATHENA study were presented today...ean Society of Cardiology,congress 2008, in Munich...
(Date:9/3/2008)...hird Clinical Trial Reconfirms Strong Evidence Pyc...ave Lasting Effect on Joints Following Cessation ...N, N.J., Sept. 3 /- According to the ...the most common type of arthritis,is on the rise....ytotherapy,Research, reveals Pycnogenol(R), bark e...
(Date:9/2/2008)... NEW YORK, Sept. 3 /- Fore...os Almirall, S.A. today announced results from,two... novel long-acting,inhaled anticholinergic for the...lmonary disease (COPD). In both the ACCLAIM/COPD I...and Safety In Moderate to,Severe COPD Patients) st...
(Date:9/2/2008)... September is Prostate Cancer Awarene...Newswire/ -- September is,Prostate Cancer Awarenes...alm Beach announce a revolutionary new way to trea...nt courses of radiation. Prostate cancer is,the mo... Morse CyberKnife CEO, James G. Schwade, M.D., sa...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 1Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 3Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 4Measurements Poor for Assessing Clinical Trials With Children 17915 1Measurements Poor for Assessing Clinical Trials With Children 17915 21 in 4 U S Toddlers Improperly Vaccinated 17913 11 in 4 U S Toddlers Improperly Vaccinated 17913 21 in 4 U S Toddlers Improperly Vaccinated 17913 3Mylan Announces Final FDA Approval for Trandolapril Tablets 17911 1
...)--Apr 10, 2007 - Bentley,Pharmaceuticals, Inc. (N...ay announced that its abstract entitled "Interim,R...er,Pharmacokinetic Study of Intranasal Insulin Sp...ulin R(R)), Injectable Fast-Acting,Insulin (Humalo...e,I Diabetes Mellitus," has been selected for oral...
...2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences I...e,Company,s clinical and preclinical pipeline, inc... export inhibitor programs, at the,2007 Annual Mee...ch,(AACR), being held in Los Angeles, April 14-18,...are as follows. The,location for all poster presen...
Other Medicine Technology:Nasulin Interim Results to Be Presented at American Diabetes,Association Scientific Sessions 2Nasulin Interim Results to Be Presented at American Diabetes,Association Scientific Sessions 3Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...f drugs are determined? How drugs are being tested...t happens if the dosages are unwittingly missed? O...ting patients what happens? Who answers these ques...n the U.S.A. has revealed that in many instances a...
Vitamins-The answer to Heart Disease?
...irus in its latest outbreak has claimed around 156...y officials in Kampala. More shocking is the fact...ng doctors & nurses. But what shocked the nation ...rominent doctor spearheading the fight against Ebo...
...nder drug we are all looking out for. According to...tly increases the cytokine production in cultured...pirulina on the immune system, immunologists at UC...ected blood samples from 12 healthy volunteers and...
Other Medicine News:
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: